Drugs / Ag-D-CIK
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02215837 | Aug 2014 → May 2018 | gastric cancer | Shenzhen Hornetcorn Bio-technology Company, LTD | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ag-D-CIK | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02215837 ↗ |
| Modality | Cell therapy | “autologous tumor lysate pulsed D-CIK cells” NCT02215837 ↗ |
| Route | Intravenous | “IV (in the vein)” NCT02215837 ↗ |